# 바이오스페이스 일일 뉴스 리포트 - 2026년 01월 06일


## 주요 헤드라인

1. **Lilly’s Path to $94B in Revenue Rests on Oral Obesity Market and Other 2026 Milestones (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/lillys-path-to-94b-in-revenue-rests-on-oral-obesity-market-and-other-2026-milestones>

2. **Lilly’s Path to $94B in Revenue Rests on Oral Obesity Market and Other 2026 Milestones (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/lillys-path-to-94b-in-revenue-rests-on-oral-obesity-market-and-other-2026-milestones>

3. **J&J Stops Mid-stage Eczema Trial as $1.25B Asset Misses Efficacy Mark (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/j-j-stops-mid-stage-eczema-trial-as-1-25b-asset-misses-efficacy-mark>

4. **J&J Stops Mid-stage Eczema Trial as $1.25B Asset Misses Efficacy Mark (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/j-j-stops-mid-stage-eczema-trial-as-1-25b-asset-misses-efficacy-mark>

5. **Takeda’s Commitment to Trial Representation is Shaping the Future of Clinical Research (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/takedas-commitment-to-trial-representation-is-shaping-the-future-of-clinical-research>

6. **5 Clinical Readouts to Watch in H1 2026 (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/5-clinical-readouts-to-watch-in-h1-2026>

7. **Big Pharma Dealmakers Joined by Spunky Group of Biotech Buyers in Q4 (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/big-pharma-dealmakers-joined-by-spunky-group-of-biotech-buyers-in-q4>


---
*2026년 01월 06일 바이오스페이스 뉴스 피드에서 생성된 리포트*